Skip to content

Research paper

Treatment for mitochondrial disorders.

The Cochrane database of systematic reviews
Q1
Apr 2012
Citations: 166
Influential: 2
Systematic Reviews / Meta-Analyses
83

Study answer

What this study found

Overall, there was no clear evidence supporting any of the reviewed pharmacological or nutritional interventions for meaningful clinical benefit in mitochondrial disorders. Some studies showed biochemical or surrogate improvements, such as increased CoQ10 levels with lower lactate at 1 minute of cycle ergometry, creatine-associated gains in handgrip strength by 19% and NIDFT by 11%, and DCA-associated reductions in lactate and brain MRS ratios, but these effects were inconsistent and did not reliably translate into clinical improvement. The larger DCA trial found no significant differences…

Study & population
Systematic review of randomized and cross-over trials in children and adults with confirmed primary mitochondrial disorders.
Intervention
This review evaluated multiple active regimens used in primary mitochondrial disorders, including coenzyme Q10, creatine monohydrate, dimethylglycine, and a whey-based cysteine supplement, compared with placebo or other inactive comparators in randomized or cross-over trials.
Key limitation
Evidence was limited by small sample sizes, heterogeneous mitochondrial phenotypes, and frequent use of cross-over designs.
View sourceOpen PDF

Original abstract

No abstract is available for this paper.